Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.080
+0.089 (8.98%)
At close: Dec 5, 2025, 4:00 PM EST
1.050
-0.030 (-2.76%)
After-hours: Dec 5, 2025, 7:20 PM EST
Hyperfine Revenue
Hyperfine had revenue of $3.44M in the quarter ending September 30, 2025, a decrease of -5.65%. This brings the company's revenue in the last twelve months to $10.59M, down -20.10% year-over-year. In the year 2024, Hyperfine had annual revenue of $12.89M with 16.84% growth.
Revenue (ttm)
$10.59M
Revenue Growth
-20.10%
P/S Ratio
7.80
Revenue / Employee
$95,414
Employees
111
Market Cap
104.94M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
HYPR News
- 15 days ago - Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - Business Wire
- 16 days ago - Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health - Business Wire
- 22 days ago - Hyperfine, Inc. (HYPR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Hyperfine, Inc. Reports Third Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025 - Business Wire
- 6 weeks ago - Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting - Business Wire
- 7 weeks ago - Hyperfine Announces Pricing of $17.5 Million Public Offering - Business Wire
- 7 weeks ago - Hyperfine Announces Proposed Public Offering - Business Wire